Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers
Clinical trial NCT03851341 · COMPLETED
Trial details
- NCT number
- NCT03851341
- Sponsor
- GL Pharm Tech Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-02
- Primary completion
- 2019-01-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.